GT Biopharma
Price & Volume
Stats
See moreOpen | $0.37 |
Previous Close | $0.36 |
Day Range | $0.35-$0.38 |
52W Range | $0.36-$3.85 |
Market Cap | $11.6M |
Shares Short | 747,375 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$6.68 |
News
See moreYahoo Finance • last month
GT Biopharma Reports Full Year 2025 Financial Results
Yahoo Finance • 4 months ago
Precision's Payoff: Targeted Therapies Drive $131B Solid Tumor Market Surge
Yahoo Finance • 5 months ago
GT Biopharma Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Yahoo Finance • 7 months ago
Friday's after hours session: top gainers and losers
About
CEO | Mr. Michael Martin Breen L.L.B. |
CFO | Mr. Alan Louis Urban CPA |
Address | 315 Montgomery Street, San Francisco, CA, United States, 94104 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 1 |
